DD291561A5 - Verfahren zur herstellung von cepherncarbonsaeureestern - Google Patents
Verfahren zur herstellung von cepherncarbonsaeureestern Download PDFInfo
- Publication number
- DD291561A5 DD291561A5 DD90337164A DD33716490A DD291561A5 DD 291561 A5 DD291561 A5 DD 291561A5 DD 90337164 A DD90337164 A DD 90337164A DD 33716490 A DD33716490 A DD 33716490A DD 291561 A5 DD291561 A5 DD 291561A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- general formula
- methyl
- och
- compound
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
- C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3901405A DE3901405A1 (de) | 1989-01-19 | 1989-01-19 | Cephalosporinderivate und verfahren zu ihrer herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
DD291561A5 true DD291561A5 (de) | 1991-07-04 |
Family
ID=6372346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD90337164A DD291561A5 (de) | 1989-01-19 | 1990-01-17 | Verfahren zur herstellung von cepherncarbonsaeureestern |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0379132A3 (pt) |
JP (1) | JPH02229196A (pt) |
CN (1) | CN1044280A (pt) |
AU (1) | AU4853690A (pt) |
CA (1) | CA2008059A1 (pt) |
DD (1) | DD291561A5 (pt) |
DE (1) | DE3901405A1 (pt) |
FI (1) | FI900270A0 (pt) |
HU (1) | HU205936B (pt) |
IL (1) | IL93086A0 (pt) |
NO (1) | NO900252L (pt) |
NZ (1) | NZ232135A (pt) |
PH (1) | PH27125A (pt) |
PT (1) | PT92890A (pt) |
TN (1) | TNSN90006A1 (pt) |
ZA (1) | ZA90361B (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3804841A1 (de) * | 1988-02-17 | 1989-08-31 | Hoechst Ag | Cephalosporinderivate und verfahren zu ihrer herstellung |
DE59209994D1 (de) * | 1991-09-07 | 2004-04-29 | Aventis Pharma Gmbh | Diastereomer des 3-Cephem-4-carbonsäure-1-(-isopropoxycarbonyloxy)ethylesters und Verfahren zu dessen Herstellung |
TW212181B (pt) * | 1992-02-14 | 1993-09-01 | Hoechst Ag | |
EP0570849B1 (de) * | 1992-05-21 | 1998-03-25 | Hoechst Aktiengesellschaft | Verfahren zur Spaltung von Cephalosporin Prodrugestern zu 7-Amino-3-methoxymethylceph-3-em-4-carbonsäure |
PA8579701A1 (es) | 2002-08-23 | 2005-05-24 | Pfizer Prod Inc | Profarmaco inhibidor de beta-lactamasa |
CN114478391B (zh) * | 2020-10-26 | 2023-09-15 | 南京锐志生物医药有限公司 | 奥硝唑酯类前药、药物组合物及其制备方法和应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2476087A1 (fr) * | 1980-02-18 | 1981-08-21 | Roussel Uclaf | Nouvelles oximes derivees de l'acide 3-alkyloxy ou 3-alkyl-thiomethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments |
US4486425A (en) * | 1980-09-30 | 1984-12-04 | Sankyo Company Limited | 7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido]-3-methoxymethyl-3-cephem-4-carboxylates |
JPS5759894A (en) * | 1980-09-30 | 1982-04-10 | Sankyo Co Ltd | Cephalosporin for oral administration |
JPS5896091A (ja) * | 1981-12-01 | 1983-06-07 | Sankyo Co Ltd | 3−アルコキシメチルセフアロスポリン類の製造法 |
JPS604189A (ja) * | 1983-06-20 | 1985-01-10 | Sankyo Co Ltd | β−ラクタム系化合物の製造法 |
-
1989
- 1989-01-19 DE DE3901405A patent/DE3901405A1/de not_active Withdrawn
-
1990
- 1990-01-16 EP EP19900100799 patent/EP0379132A3/de not_active Withdrawn
- 1990-01-17 DD DD90337164A patent/DD291561A5/de not_active IP Right Cessation
- 1990-01-17 CN CN90100248A patent/CN1044280A/zh active Pending
- 1990-01-17 HU HU90172A patent/HU205936B/hu not_active IP Right Cessation
- 1990-01-17 FI FI900270A patent/FI900270A0/fi not_active Application Discontinuation
- 1990-01-17 PH PH39900A patent/PH27125A/en unknown
- 1990-01-17 IL IL93086A patent/IL93086A0/xx unknown
- 1990-01-17 NZ NZ232135A patent/NZ232135A/en unknown
- 1990-01-17 AU AU48536/90A patent/AU4853690A/en not_active Abandoned
- 1990-01-18 ZA ZA90361A patent/ZA90361B/xx unknown
- 1990-01-18 NO NO90900252A patent/NO900252L/no unknown
- 1990-01-18 PT PT92890A patent/PT92890A/pt unknown
- 1990-01-18 CA CA002008059A patent/CA2008059A1/en not_active Abandoned
- 1990-01-19 JP JP2010436A patent/JPH02229196A/ja active Pending
- 1990-01-19 TN TNTNSN90006A patent/TNSN90006A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
NO900252D0 (no) | 1990-01-18 |
HUT54165A (en) | 1991-01-28 |
AU4853690A (en) | 1990-07-26 |
PH27125A (en) | 1992-03-16 |
NZ232135A (en) | 1991-07-26 |
JPH02229196A (ja) | 1990-09-11 |
HU205936B (en) | 1992-07-28 |
FI900270A0 (fi) | 1990-01-17 |
DE3901405A1 (de) | 1990-07-26 |
TNSN90006A1 (fr) | 1991-03-05 |
CN1044280A (zh) | 1990-08-01 |
HU900172D0 (en) | 1990-03-28 |
IL93086A0 (en) | 1990-11-05 |
NO900252L (no) | 1990-07-20 |
PT92890A (pt) | 1990-07-31 |
EP0379132A2 (de) | 1990-07-25 |
EP0379132A3 (de) | 1992-01-08 |
CA2008059A1 (en) | 1990-07-19 |
ZA90361B (en) | 1990-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2727753C2 (pt) | ||
DE2713272C2 (de) | Derivate der 7-Aminothiazolyl-acetamido-cephalosporansäure, ihre Herstellung und pharmazeutische Zusammensetzungen | |
DE3311300C2 (pt) | ||
DE2736471C2 (pt) | ||
CH617202A5 (pt) | ||
EP0329008B1 (de) | Cephalosporinderivative und Verfahren zu ihrer Herstellung | |
CH666274A5 (de) | Cephalosporin-antibiotika. | |
EP0280157B1 (de) | Kristallisierte Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung | |
DD282691A5 (de) | Verfahren zur herstellung von cephalosporin | |
DD291561A5 (de) | Verfahren zur herstellung von cepherncarbonsaeureestern | |
EP0033518B1 (de) | Kristalline Salze eines Cephalosporins, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen | |
DE69109913T2 (de) | Cephalosporinzwischenverbindungen, Verfahren zu ihrer Herstellung sowie zur Herstellung ihrer Endprodukte. | |
DE2444321A1 (de) | 7-(halogenmethylaryl)-acetamidocephalosporinderivate, verfahren zu ihrer herstellung und arzneimittel | |
DE3780909T2 (de) | 7-((meta-substituiert)-phenylglycin)-1-carba-1-dethia-cephalosporine. | |
DE1670301C3 (de) | 7- (Pyndylmercaptoacetamido) cephalosporansäuren, deren Salze und Verfahren zu ihrer Herstellung | |
DE2234280B2 (de) | Cephalosporinverbindungen und Verfahren zu deren Herstellung | |
DE69028285T2 (de) | Cephalosporinderivate, ihre Herstellung und Anwendungen | |
AT391319B (de) | Verfahren zur herstellung von neuen cephalosporinverbindungen | |
DE3809561A1 (de) | Ester der 7-(2-(2-aminothiazol-4-yl)-2-(z)- hydroxyiminoacetamido)-3-methoxymethyl-3-cephem-4-carbonsaeure, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen | |
DE69706321T2 (de) | Cephemderivate | |
EP0390066B1 (de) | Cephalosporinderivate und Verfahren zu ihrer Herstellung | |
DE2818985C2 (de) | Halogenarylmalonamidooxacephalosporine und deren Verwendung bei der Bekämpfung bakterieller Infektionen | |
CH634326A5 (de) | 2-hydroxyiminoacetamido-cephemcarbonsaeuren und ihre herstellung. | |
EP0553792A2 (de) | Verfahren zur Herstellung von Ceftriaxon-dinatriumsalzhemiheptahydrat | |
DE2539676C3 (de) | 3-Cyanopenamverbindungen und Verfahren zu deren Herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENJ | Ceased due to non-payment of renewal fee |